Company Filing History:
Years Active: 2013-2016
Title: Chatarina Lofqvist: Innovator in Prematurity Treatment
Introduction
Chatarina Lofqvist is a notable inventor based in Askim, Sweden. She has made significant contributions to the field of medicine, particularly in the treatment of complications arising from prematurity. With a total of 2 patents to her name, her work is paving the way for advancements in neonatal care.
Latest Patents
Lofqvist's latest patents focus on innovative methods for treating complications associated with preterm birth. One of her patents, titled "Methods for treatment of complications of prematurity comprising administration of IGF-I and IGFBP-3," describes a composition that combines Insulin Growth Factor I (IGF-I) with Insulin Growth Factor Binding Protein (IGFBP). This combination is designed to be administered to patients suffering from complications of preterm birth, with a specific molar ratio that enhances its effectiveness. Another patent, "Method and product for treatment and/or prevention of complications of prematurity," outlines a similar composition and method, emphasizing the importance of the molar ratio in achieving optimal treatment outcomes.
Career Highlights
Chatarina Lofqvist is currently associated with Premacure AB, a company dedicated to developing therapies for premature infants. Her work at Premacure AB has been instrumental in advancing research and treatment options for this vulnerable population.
Collaborations
Lofqvist collaborates with Lois Elaine Smith, a fellow researcher in the field. Their partnership is focused on enhancing the understanding and treatment of complications related to prematurity.
Conclusion
Chatarina Lofqvist's innovative contributions to the treatment of complications from prematurity highlight her dedication to improving neonatal health. Her patents and work at Premacure AB are significant steps forward in this critical area of medicine.